Correspondence 0001213900-23-004444 from Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786) (HOTH)
Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786)
Date: Jan. 23, 2023 · CIK: 0001711786 · Accession: 0001213900-23-004444
AI Filing Summary & Sentiment
File numbers found in text: 333-269224
Show Raw Text
CORRESP
1
filename1.htm
Hoth Therapeutics, Inc.
1 Rockefeller Plaza, Suite 1039
New York, New York 10020
January 23, 2023
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Arzhang Navai
Re:
Hoth Therapeutics, Inc.
Registration Statement on Form S-3
Filed January 13, 2023
File No. 333-269224
Ladies and Gentlemen:
Pursuant to Rule 461
of the General Rules and Regulations under the Securities Act of 1933, as amended, Hoth Therapeutics, Inc. (the “Company”)
respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective
at 5:00 p.m., Eastern Standard Time, on Wednesday, January 25, 2023, or as soon thereafter as possible.
Please notify Nazia Khan of
Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (202) 747-2651 as soon as possible as to the time the Registration
Statement has been declared effective pursuant to this acceleration request.
HOTH THERAPEUTICS, INC.
By:
/s/ Robb Knie
Name:
Robb Knie
Title:
Chief Executive Officer